Strategic account executives are key to achieving a best-in-class pharmacy benefit plan with National CooperativeRx. They wear many hats within the Cooperative and are right
In 2021, the U.S. healthcare system spent $603 billion on prescription drugs before rebates. While only 20% of the prescription drugs filled were brand-name drugs,
As a community, we accomplish more together than we can alone. The support of a community becomes even more important when faced with challenges from
The expiration of the Humira® (adalimumab) patent has been long and enthusiastically anticipated and is finally upon us in 2023. And, as we all have
2022 is coming to an end, leaving many eager to see what the new year has in store. What can we expect in the pharmacy
At National CooperativeRx, we conduct an annual member and partner satisfaction survey to assess our performance, the importance of specific National CooperativeRx aspects, and the
